Harmony Biosciences has an Enterprise Value (EV) of 1.68B.
2.36
7.21
7.66
7.7
Financial Position
The company has a current ratio of 3.31,
with a Debt / Equity ratio of 0.27.
3.31
3.27
0.27
0.77
0.82
10.91
Financial Efficiency
Return on Equity is 22.07% and Return on Invested Capital is 17.22%.
22.07%
14.56%
17.22%
$2.67M
$542.88K
268
0.72
21.79
Taxes
46.31M
24.14%
Stock Price Statistics
The stock price has increased by 4.25% in the
last 52 weeks. The beta is 0.84, so Harmony Biosciences's
price volatility has been higher than the market average.
0.84
4.25%
34.24
34.13
45.79
637,469
Income Statement
In the last 12 months, Harmony Biosciences had revenue of 714.73M
and earned 145.49M
in profits. Earnings per share was 2.56.